Multiple Adverse Outcomes Associated with Risperidone in People with Dementia: An Individual Participant Data Meta-Analysis.

The presence of psychosis at baseline was associated with a lower risk of MACE in the risperidone group (HR 0.42; 95% CI 0.21–0.82; p = 0.012) and in the placebo group (HR 0.55; 95% CI 0.18–1.63; p = 0.278), although the latter did not reach statistical significance.

also in 111,027 other papers